|
Model Number 8300AB |
Device Problems
Degraded (1153); Fluid/Blood Leak (1250); Gradient Increase (1270); Difficult to Open or Close (2921); Insufficient Information (3190)
|
Patient Problems
Cardiogenic Shock (2262); Insufficient Information (4580)
|
Event Date 09/08/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
H10: additional narratives: surgical/percutaneous intervention is indicated or performed, or harm occurred due to the device, or there is a device malfunction that could cause or contribute to a serious injury.This event is considered a serious injury.The device was not returned for evaluation, as it remains implanted.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
|
|
Event Description
|
It was learned via implant patient registry that a 21mm aortic valve was disabled via a valve-in-valve procedure after an implant duration of 3 years, 1 month due to unknown reasons.A 20mm transcatheter valve was implanted.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.
|
|
Manufacturer Narrative
|
H10: additional narratives: updated b3, b5, b7, and h6 per new information received.
|
|
Event Description
|
It was learned via implant patient registry that a 8300ab 21mm aortic valve was disabled via a valve-in-valve procedure after an implant duration of 3 years, 1 month due to degeneration, leaflet thickening, restricted leaflet motion, severe stenosis, and moderate regurgitation.The patient presented with cardiogenic shock.A 9750tfx 20mm transcatheter valve was implanted.Concomitantly, the patient underwent transcatheter mitral valve in valve ((b)(4)) with a 29 mm sapien 3 ultra.
|
|
Manufacturer Narrative
|
H10: additional narratives: the most likely cause is patient factors, including coronary artery disease and history of coronary artery bypass graft.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Search Alerts/Recalls
|
|
|